id,sequence,label,elisa_flags,source
abituzumab,GYTFSSFW,0.0,0,jain2017_pnas
abrilumab,GYTLSDLS,0.0,0,jain2017_pnas
adalimumab,GFTFDDYA,0.0,0,jain2017_pnas
alemtuzumab,GFTFTDFY,0.0,0,jain2017_pnas
alirocumab,GFTFNNYA,0.0,0,jain2017_pnas
anifrolumab,GYIFTNYW,0.0,0,jain2017_pnas
atezolizumab,GFTFSDSW,0.0,0,jain2017_pnas
bapineuzumab,GFTFSNYG,0.0,0,jain2017_pnas
basiliximab,GYSFTRYW,0.0,0,jain2017_pnas
bavituximab,GYSFTGYN,0.0,0,jain2017_pnas
belimumab,GGTFNNNA,1.0,6,jain2017_pnas
benralizumab,GYTFTSYV,0.0,0,jain2017_pnas
bevacizumab,GYTFTNYG,0.0,0,jain2017_pnas
bimagrumab,GYTFTSSY,0.0,0,jain2017_pnas
blosozumab,GFPIKDTF,1.0,6,jain2017_pnas
bococizumab,GYTFTSYY,1.0,6,jain2017_pnas
brentuximab,GYTFTDYY,,3,jain2017_pnas
briakinumab,GFTFSSYG,1.0,4,jain2017_pnas
brodalumab,GYTFTRYG,,1,jain2017_pnas
canakinumab,GFTFSVYG,0.0,0,jain2017_pnas
carlumab,GGTFSSYG,1.0,4,jain2017_pnas
certolizumab,GYVFTDYG,0.0,0,jain2017_pnas
cetuximab,GFSLTNYG,0.0,0,jain2017_pnas
cixutumumab,GGTFSSYA,1.0,6,jain2017_pnas
clazakizumab,GFSLSNYY,0.0,0,jain2017_pnas
codrituzumab,GYTFTDYE,1.0,6,jain2017_pnas
crenezumab,GFTFSSYG,0.0,0,jain2017_pnas
dacetuzumab,GYSFTGYY,0.0,0,jain2017_pnas
daclizumab,GYTFTSYR,,1,jain2017_pnas
dalotuzumab,GYSITGGYL,1.0,5,jain2017_pnas
daratumumab,GFTFNSFA,0.0,0,jain2017_pnas
denosumab,GFTFSSYA,1.0,5,jain2017_pnas
dinutuximab,GSSFTGYN,0.0,0,jain2017_pnas
drozitumab,GFTFDDYA,0.0,0,jain2017_pnas
duligotuzumab,GFTLSGDW,1.0,6,jain2017_pnas
dupilumab,GFTFRDYA,1.0,5,jain2017_pnas
eculizumab,GYIFSNYW,0.0,0,jain2017_pnas
efalizumab,GYSFTGHW,0.0,0,jain2017_pnas
eldelumab,GFTFSNNG,0.0,0,jain2017_pnas
elotuzumab,GFDFSRYW,0.0,0,jain2017_pnas
emibetuzumab,GYTFTDYY,1.0,6,jain2017_pnas
enokizumab,GGTFSYYW,0.0,0,jain2017_pnas
epratuzumab,GYTFTSYW,,1,jain2017_pnas
etrolizumab,GFFITNNY,,2,jain2017_pnas
evolocumab,GYTLTSYG,,2,jain2017_pnas
farletuzumab,GFTFSGYG,0.0,0,jain2017_pnas
fasinumab,GFTLTELS,0.0,0,jain2017_pnas
fezakinumab,GYTFTNYY,0.0,0,jain2017_pnas
ficlatuzumab,GYTFTTYW,0.0,0,jain2017_pnas
figitumumab,GFTFSSYA,,3,jain2017_pnas
fletikumab,GYTFTNDI,0.0,0,jain2017_pnas
foralumab,GFKFSGYG,,2,jain2017_pnas
fresolimumab,GYTFSSNV,0.0,0,jain2017_pnas
fulranumab,GFTLRSYS,,1,jain2017_pnas
galiximab,GGSISGGYG,0.0,0,jain2017_pnas
ganitumab,GGSISSSNW,0.0,0,jain2017_pnas
gantenerumab,GFTFSSYA,1.0,6,jain2017_pnas
gemtuzumab,GYTITDSN,0.0,0,jain2017_pnas
gevokizumab,GFSLSTSGMG,0.0,0,jain2017_pnas
girentuximab,GFTFSNYY,0.0,0,jain2017_pnas
glembatumumab,GGSISSFNYY,0.0,0,jain2017_pnas
golimumab,GFIFSSYA,,1,jain2017_pnas
guselkumab,GYSFSNYW,,1,jain2017_pnas
ibalizumab,GYTFTSYV,0.0,0,jain2017_pnas
imgatuzumab,GFTFTDYK,1.0,5,jain2017_pnas
infliximab,GFIFSNHW,0.0,0,jain2017_pnas
inotuzumab,GYRFTNYW,,3,jain2017_pnas
ipilimumab,GFTFSSYT,0.0,0,jain2017_pnas
ixekizumab,GYSFTDYH,1.0,6,jain2017_pnas
lampalizumab,GYTFTNYG,0.0,0,jain2017_pnas
lebrikizumab,GFSLSAYS,0.0,0,jain2017_pnas
lenzilumab,GYSFTNYY,1.0,6,jain2017_pnas
lintuzumab,GYTFTDYN,0.0,0,jain2017_pnas
lirilumab,GGTFSFYA,0.0,0,jain2017_pnas
lumiliximab,GFRFTFNNYY,0.0,0,jain2017_pnas
matuzumab,GYTFTSHW,0.0,0,jain2017_pnas
mavrilimumab,GYTLTELS,0.0,0,jain2017_pnas
mepolizumab,GFSLTSYS,0.0,0,jain2017_pnas
mogamulizumab,GFIFSNYG,0.0,0,jain2017_pnas
motavizumab,GFSLSTAGMS,,1,jain2017_pnas
muromonab,GYTFTRYT,0.0,0,jain2017_pnas
natalizumab,GFNIKDTY,0.0,0,jain2017_pnas
necitumumab,GGSISSGDYY,0.0,0,jain2017_pnas
nimotuzumab,GYTFTNYY,0.0,0,jain2017_pnas
nivolumab,GITFSNSG,0.0,0,jain2017_pnas
obinutuzumab,GYAFSYSW,0.0,0,jain2017_pnas
ocrelizumab,GYTFTSYN,0.0,0,jain2017_pnas
ofatumumab,GFTFNDYA,0.0,0,jain2017_pnas
olaratumab,GGSINSSSYY,0.0,0,jain2017_pnas
olokizumab,GFNFNDYF,0.0,0,jain2017_pnas
omalizumab,GYSITSGYS,0.0,0,jain2017_pnas
onartuzumab,GYTFTSYW,0.0,0,jain2017_pnas
otelixizumab,GFTFSSFP,0.0,0,jain2017_pnas
otlertuzumab,GYSFTGYN,0.0,0,jain2017_pnas
ozanezumab,GYTFTSYW,,3,jain2017_pnas
palivizumab,GFSLSTSGMS,0.0,0,jain2017_pnas
panitumumab,GGSVSSGDYY,0.0,0,jain2017_pnas
panobacumab,GFTFSPYW,0.0,0,jain2017_pnas
parsatuzumab,GYTFIDYY,1.0,6,jain2017_pnas
patritumab,GGSFSGYY,1.0,4,jain2017_pnas
pembrolizumab,GYTFTNYY,0.0,0,jain2017_pnas
pertuzumab,GFTFTDYT,0.0,0,jain2017_pnas
pinatuzumab,GYEFSRSW,0.0,0,jain2017_pnas
polatuzumab,GYTFSSYW,0.0,0,jain2017_pnas
ponezumab,GYYTEAYY,1.0,4,jain2017_pnas
radretumab,GFTFSSFS,0.0,0,jain2017_pnas
ramucirumab,GFTFSSYS,0.0,0,jain2017_pnas
ranibizumab,GYDFTHYG,,1,jain2017_pnas
reslizumab,GLSLTSNS,0.0,0,jain2017_pnas
rilotumumab,GGSISIYY,0.0,0,jain2017_pnas
rituximab,GYTFTSYN,0.0,0,jain2017_pnas
robatumumab,GFTFSSFA,1.0,4,jain2017_pnas
romosozumab,GYTFTDYN,0.0,0,jain2017_pnas
sarilumab,RFTFDDYA,0.0,0,jain2017_pnas
secukinumab,GFTFSNYW,0.0,0,jain2017_pnas
seribantumab,GFTFSHYV,0.0,0,jain2017_pnas
sifalimumab,GYTFTSYS,,3,jain2017_pnas
siltuximab,GFTFSSFA,0.0,0,jain2017_pnas
simtuzumab,GYAFTYYL,1.0,6,jain2017_pnas
sirukumab,GFTFSPFA,1.0,5,jain2017_pnas
tabalumab,GGSFSGYY,0.0,0,jain2017_pnas
tanezumab,GFSLIGYD,,1,jain2017_pnas
teplizumab,GYTFTRYT,,2,jain2017_pnas
tigatuzumab,GFTFSSYV,0.0,0,jain2017_pnas
tildrakizumab,GYIFITYW,0.0,0,jain2017_pnas
tocilizumab,GYSITSDHA,0.0,0,jain2017_pnas
tovetumab,GFTFSDYY,0.0,0,jain2017_pnas
tralokinumab,GYTFTNYG,0.0,0,jain2017_pnas
trastuzumab,GFNIKDTY,0.0,0,jain2017_pnas
tremelimumab,GFTFSSYG,0.0,0,jain2017_pnas
urelumab,GGSFSGYY,0.0,0,jain2017_pnas
ustekinumab,GYSFTTYW,,3,jain2017_pnas
vedolizumab,GYTFTSYW,0.0,0,jain2017_pnas
veltuzumab,GYTFTSYN,0.0,0,jain2017_pnas
visilizumab,GYTFISYT,,3,jain2017_pnas
zalutumumab,GFTFSTYG,,1,jain2017_pnas
zanolimumab,GGSFSGYY,0.0,0,jain2017_pnas
